Hersh E - Search Results

1

A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.

Ebbinghaus S, Rubin E, Hersh E, Cranmer LD, Bonate PL, Fram RJ, Jekunen A, Weitman S, Hammond LA. Ebbinghaus S, et al. Among authors: hersh e. Clin Cancer Res. 2005 Nov 1;11(21):7807-16. doi: 10.1158/1078-0432.CCR-05-0909. Clin Cancer Res. 2005. PMID: 16278403 Clinical Trial.

2

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.

Hersh EM, O'Day SJ, Powderly J, Khan KD, Pavlick AC, Cranmer LD, Samlowski WE, Nichol GM, Yellin MJ, Weber JS. Hersh EM, et al. Invest New Drugs. 2011 Jun;29(3):489-98. doi: 10.1007/s10637-009-9376-8. Epub 2010 Jan 16. Invest New Drugs. 2011. PMID: 20082117 Clinical Trial.

3

Ipilimumab pharmacotherapy in patients with metastatic melanoma.

Jeter JM, Cranmer LD, Hersh EM. Jeter JM, et al. Clin Med Insights Oncol. 2012;6:275-86. doi: 10.4137/CMO.S7245. Epub 2012 Jul 30. Clin Med Insights Oncol. 2012. PMID: 22904648 Free PMC article.

4

The role of the CTLA4 blockade in the treatment of malignant melanoma.

Cranmer LD, Hersh E. Cranmer LD, et al. Among authors: hersh e. Cancer Invest. 2007 Oct;25(7):613-31. doi: 10.1080/07357900701522315. Cancer Invest. 2007. PMID: 18027152 Review.

5

Clinical applications of dendritic cell vaccination in the treatment of cancer.

Cranmer LD, Trevor KT, Hersh EM. Cranmer LD, et al. Cancer Immunol Immunother. 2004 Apr;53(4):275-306. doi: 10.1007/s00262-003-0432-5. Epub 2003 Nov 26. Cancer Immunol Immunother. 2004. PMID: 14648069 Free PMC article. Review.

6

Rodent models of brain metastasis in melanoma.

Cranmer LD, Trevor KT, Bandlamuri S, Hersh EM. Cranmer LD, et al. Melanoma Res. 2005 Oct;15(5):325-56. doi: 10.1097/00008390-200510000-00002. Melanoma Res. 2005. PMID: 16179861 Review.

7

Phase I trial of imexon in patients with advanced malignancy.

Dragovich T, Gordon M, Mendelson D, Wong L, Modiano M, Chow HH, Samulitis B, O'Day S, Grenier K, Hersh E, Dorr R. Dragovich T, et al. Among authors: hersh e. J Clin Oncol. 2007 May 1;25(13):1779-84. doi: 10.1200/JCO.2006.08.9672. J Clin Oncol. 2007. PMID: 17470869 Clinical Trial.

8

Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.

McDermott DF, Sosman JA, Gonzalez R, Hodi FS, Linette GP, Richards J, Jakub JW, Beeram M, Tarantolo S, Agarwala S, Frenette G, Puzanov I, Cranmer L, Lewis K, Kirkwood J, White JM, Xia C, Patel K, Hersh E. McDermott DF, et al. Among authors: hersh e. J Clin Oncol. 2008 May 1;26(13):2178-85. doi: 10.1200/JCO.2007.14.8288. J Clin Oncol. 2008. PMID: 18445842 Clinical Trial.

9

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies.

Nyman DW, Campbell KJ, Hersh E, Long K, Richardson K, Trieu V, Desai N, Hawkins MJ, Von Hoff DD. Nyman DW, et al. Among authors: hersh e. J Clin Oncol. 2005 Nov 1;23(31):7785-93. doi: 10.1200/JCO.2004.00.6148. J Clin Oncol. 2005. PMID: 16258082 Clinical Trial.

10

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.

Stopeck AT, Jones A, Hersh EM, Thompson JA, Finucane DM, Gutheil JC, Gonzalez R. Stopeck AT, et al. Among authors: hersh em. Clin Cancer Res. 2001 Aug;7(8):2285-91. Clin Cancer Res. 2001. PMID: 11489803 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

626 results

Search Page

Filters